Doctor profile · Federal record
Dr. David di Cesar, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · East Syracuse, NY
- NPI 1689837734
- 24 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5000 Brittonfield Pkwy Ste B150
East Syracuse, NY 130579215
(315) 766-1627
fax (315) 201-8711 - Mailing address
-
1001 W Fayette St, Suite 400
Syracuse, NY 132042859
Credentials & registration
- NPI registered
- July 2008 — 18 yrs on file
- Profile last updated
- September 2, 2025
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- New York #003333
- Medicaid
- NY #03112636
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1689837734. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,343
Distinct HCPCS
7
Medicare allowed
$116,505
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 1,680 | 19 | $23 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 381 | 221 | $174 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 192 | 84 | $34 | |
96372 |
Injection of drug or substance under skin or into muscle | 42 | 28 | $14 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 25 | 21 | $125 | |
G0008 |
Administration of influenza virus vaccine | 12 | 12 | $27 | |
90694 |
Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 11 | 11 | $76 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 334. This provider delivers 7.0× the peer median.Open Payments
Industry payments received
All-time total
$47,109
Transactions
148
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 43 | $19,860.67 | |
| Dexcom, Inc. | 17 | $19,184.89 | |
| SANOFI-AVENTIS U.S. LLC | 5 | $6,202.66 | |
| Lilly USA, LLC | 24 | $334.07 | |
| Medtronic, Inc. | 5 | $246.07 | |
| Amgen Inc. | 11 | $208.54 | |
| Abbott Laboratories | 10 | $177.31 | |
| Novartis Pharmaceuticals Corporation | 8 | $174.90 | |
| PFIZER INC. | 4 | $88.39 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83.01 | |
| IBSA Pharma Inc. | 4 | $71.50 | |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $69.48 | |
| ABBVIE INC. | 4 | $65.84 | |
| BETA BIONICS, INC. | 3 | $65.43 | |
| Insulet Corporation | 2 | $43.46 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,732
Patients
431
Total drug cost
$1,386,720
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 497 | 125 | $10,665 |
| Ozempic (Semaglutide) | Brand | 325 | 76 | $669,020 |
| Synthroid (Levothyroxine Sodium) | Brand | 172 | 40 | $13,978 |
| Metformin Hcl | Generic | 129 | 34 | $1,452 |
| Jardiance (Empagliflozin) | Brand | 123 | 41 | $197,022 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 82 | 29 | $118,420 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 77 | 27 | $1,986 |
| Novolog Flexpen (Insulin Aspart) | Brand | 49 | 11 | $79,822 |
| Insulin Lispro | Generic | 47 | 11 | $9,059 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 46 | 15 | $63,615 |
Hospital affiliations
Frequently asked questions
What is Dr. David di Cesar's medical specialty?
Dr. David di Cesar practices Endocrinology, Diabetes & Metabolism Physician in East Syracuse, NY.
Where does Dr. David di Cesar practice?
Dr. David di Cesar practices at 5000 Brittonfield Pkwy Ste B150, East Syracuse, NY 130579215. Office phone: 3157661627.
What is Dr. David di Cesar's NPI?
Dr. David di Cesar's National Provider Identifier (NPI) is 1689837734, issued by NPPES.
Does Dr. David di Cesar accept Medicare assignment?
Dr. David di Cesar does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. David di Cesar commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99215); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.